Regenxbio has a competitive advantage in the market with its proprietary NAV technology platform, based on AAV vectors, that is highly effective, efficient, and scalable. The recent Phase II trial on ...

Remnants of Vector Launch have made it back to one of its original architects after Phantom Space bought launch assets that were sold off in 2020 during the small rocket developer’s bankruptcy.

SAN FRANCISCO--(BUSINESS WIRE)--Vector Capital (“Vector”), a leading private equity firm specializing in transformational investments in established technology businesses, today announced it has ...

Vector and Nammo Defense Systems partner to produce NDAA-compliant, kinetically-integrated UAS platforms for small-drone battlefield deployment.

SAN FRANCISCO--(BUSINESS WIRE)--Vector Capital (“Vector”), a leading private equity firm specializing in transformational investments in established technology businesses, today announced the ...

Based in San Francisco, Vector Capital invests in middle-market technology and technology-enabled businesses Vector was founded in 1997 Vector Capital has agreed to acquire San Francisco-based ...

Introgen Therapeutic’s (Austin, TX) p53-based INGN 225 cancer vaccine yielded promising safety and efficacy results in a Phase II trial in advanced small cell lung cancer. The personalized therapeutic ...

Demand for lentiviral vectors will continue to outstrip supply until the industry has access to more efficient, purpose-built manufacturing and bioprocessing technologies. The warning comes from ...